Pre-transplant IE1-specific T-cell response and CD8+ T-cell count as predictive markers of treated HCMV reactivation in kidney transplant recipients
Lymphocyte counts and HCMV-specific T-cell response can be measured at pre-transplant in KTRs in order to efficiently predict the risk of treated HCMV reactivation during the first year after transplant. Potential cut-off and diagnostics algorithm should be better investigated in a large patients setting.
Authors
- Teresa Rampino (ORCID: https://orcid.org/0000-0002-5311-9174)
- Marilena Gregorini (ORCID: https://orcid.org/0000-0003-1440-6872)
- Fausto Baldanti (ORCID: https://orcid.org/0000-0002-3358-8969)
- Daniele Lilleri (ORCID: https://orcid.org/0000-0001-7747-7622)
- Maria Antonietta Grignano (ORCID: https://orcid.org/0000-0003-1439-7662)
- Federica Zavaglio (ORCID: https://orcid.org/0000-0001-5471-1711)
- Irene Cassanti
Institutions
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1538795
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00